| |
| |
|
| Insider
Information: |
Gerberding Julie L. |
| Relationship: |
Director |
| City: |
Kenilworth |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
105,769 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,025,458 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
105,769 |
|
|
| Total
Value |
$8,025,458 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 3.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Merck & Co Inc |
MRK |
EVP, Chief Patient Off... |
2022-02-24 |
48,712 |
|
0 |
Premium* |
|
|
Cerner Corp |
CERN |
Director |
2021-05-19 |
15,032 |
2017-05-24 |
0 |
Premium* |
|
|
Hillevax, Inc. |
HLVX |
Director |
2022-04-28 |
42,025 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HLVX |
Hillevax, Inc. |
Director |
– • – |
2022-04-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
42,025 |
|
- |
|
| MRK |
Merck & Co Inc |
EVP, Chief Patient Officer |
• • – |
2022-02-24 |
4 |
A |
$73.51 |
$702,021 |
D/D |
9,550 |
48,712 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP, Chief Patient Officer |
• • – |
2021-11-01 |
4 |
S |
$87.91 |
$8,462,682 |
D/D |
(96,270) |
39,162 |
0 |
% |
|
| MRK |
Merck & Co Inc |
EVP, Chief Patient Officer |
• • – |
2021-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,270 |
135,432 |
0 |
- |
|
| CERN |
Cerner Corp |
Director |
– • – |
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,188 |
15,032 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, GI Pub Policy |
• • – |
2021-02-26 |
4 |
A |
$72.62 |
$913,923 |
D/D |
12,585 |
39,162 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, GI Pub Policy |
• • – |
2020-07-17 |
4 |
AS |
$80.00 |
$2,902,976 |
D/D |
(36,285) |
26,577 |
0 |
% |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, GI Pub Policy |
• • – |
2020-07-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,111 |
62,862 |
0 |
- |
|
| CERN |
Cerner Corp |
Director |
– • – |
2020-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,716 |
11,844 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, GI Pub Policy |
• • – |
2020-02-28 |
4 |
A |
$76.56 |
$564,324 |
D/D |
7,371 |
44,409 |
0 |
- |
|
| CERN |
Cerner Corp |
Director |
– • – |
2019-08-22 |
4 |
S |
$71.82 |
$569,389 |
D/D |
(7,928) |
8,128 |
0 |
- |
|
| CERN |
Cerner Corp |
Director |
– • – |
2019-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,556 |
16,056 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, Gl Pub Policy |
• • – |
2019-02-25 |
4 |
A |
$80.38 |
$703,084 |
D/D |
8,747 |
55,288 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, Gl Pub Policy |
• • – |
2018-11-07 |
4 |
S |
$75.14 |
$2,721,348 |
D/D |
(36,218) |
46,263 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, Gl Pub Policy |
• • – |
2018-11-07 |
4 |
OE |
$54.68 |
$1,980,400 |
D/D |
36,218 |
82,481 |
0 |
- |
|
| CERN |
Cerner Corp |
Director |
– • – |
2018-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,100 |
12,500 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, Gl Pub Policy |
• • – |
2018-05-15 |
4 |
S |
$59.66 |
$594,963 |
D/D |
(9,972) |
45,717 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, Gl Pub Policy |
• • – |
2018-02-27 |
4 |
A |
$54.72 |
$495,873 |
D/D |
9,062 |
55,277 |
0 |
- |
|
| CERN |
Cerner Corp |
Director |
– • – |
2017-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,900 |
8,400 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, Gl Pub Policy |
• • – |
2017-05-02 |
4 |
D |
$62.38 |
$67,246 |
D/D |
(1,078) |
45,338 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, Gl Pub Policy |
• • – |
2017-05-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,092 |
46,416 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, Gl Pub Policy |
• • – |
2016-11-07 |
4 |
S |
$60.02 |
$5,133,330 |
D/D |
(85,523) |
39,115 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, Gl Pub Policy |
• • – |
2016-11-07 |
4 |
OE |
$36.56 |
$3,551,946 |
D/D |
85,523 |
124,638 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, Gl Pub Policy |
• • – |
2016-05-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,002 |
40,221 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP Strat Comm, Gl Pub Policy |
• • – |
2016-05-06 |
4 |
D |
$54.09 |
$84,705 |
D/D |
(1,566) |
38,655 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
